Elevated Ccr2 and Ccl2 expression have been previously observed in the dorsal root ganglia following the administration of another anticancer agent, paclitaxel, and this was positively correlated with peripheral neuropathy [69]. The gene discussed is CCR2; the disease is peripheral neuropathy.